Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Pulmonary Tuberculosis I
Pulmonary Tuberculosis II
Pulmonary Tuberculosis V
Pulmonary Tuberculosis III
Pulmonary Tuberculosis IV
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Justin T Okano1, Sally Blower1
1Center for Biomedical Modeling, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
No abstract available in PubMed .